FAKTOR-OPTIONSSCHEIN - IPSEN | Market Closed - Börse Stuttgart 02:17:39 2024-06-07 pm EDT | ||
| 7.76 EUR | -0.26% |
|
| Current month | -3.00% | ||
| 1 month | -14.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 7.76 | -0.26% |
| 24-06-06 | 7.78 | +0.52% |
| 24-06-05 | 7.74 | -1.90% |
| 24-06-04 | 7.89 | -0.38% |
| 24-06-03 | 7.92 | -1.00% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 02:17 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Morgan Stanley |
| WKN | MG1K9V |
| ISIN | DE000MG1K9V0 |
| Date issued | 2024-04-03 |
| Strike | 184.2 € |
| Maturity | Unlimited |
| Parity | 7.91 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.98 € |
|---|---|
| Lowest since issue | 7.7 € |
| Spread | 0.02 € |
| Spread % | 0.26% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
122.9
EUR
Average target price
126.4
EUR
Spread / Average Target
+2.85%
- Stock Market
- Certificates
- Certificat
